Last updated 16 days ago

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

182 patients around the world
Available in Spain, Brazil, United States
Hoffmann-La Roche
1Research sites
182Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Mantle cell lymphoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Recruiting
Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy